IL-23

Showing 1 posts of 1 posts found.

abbvieuse_054_low

AbbVie’s psoriasis drug smashes all endpoints

October 26, 2017
Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab

AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …

Latest content